Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
18.58
Dollar change
+0.03
Percentage change
0.16
%
IndexRUT P/E27.01 EPS (ttm)0.69 Insider Own1.14% Shs Outstand62.60M Perf Week-2.47%
Market Cap1.17B Forward P/E10.83 EPS next Y1.72 Insider Trans0.00% Shs Float61.89M Perf Month-7.56%
Income64.59M PEG1.40 EPS next Q0.37 Inst Own117.34% Short Float17.33% Perf Quarter-7.29%
Sales366.55M P/S3.18 EPS this Y-80.68% Inst Trans-1.30% Short Ratio17.57 Perf Half Y16.78%
Book/sh10.68 P/B1.74 EPS next Y303.53% ROA5.34% Short Interest10.73M Perf Year18.34%
Cash/sh4.16 P/C4.47 EPS next 5Y19.34% ROE9.97% 52W Range14.32 - 21.28 Perf YTD15.84%
Dividend Est.- P/FCF7.18 EPS past 5Y-9.02% ROI6.97% 52W High-12.69% Beta0.53
Dividend TTM- Quick Ratio1.64 Sales past 5Y1146.35% Gross Margin77.52% 52W Low29.70% ATR (14)0.41
Dividend Ex-DateSep 08, 2015 Current Ratio1.79 EPS Y/Y TTM23.54% Oper. Margin43.99% RSI (14)35.11 Volatility1.88% 2.27%
Employees112 Debt/Eq0.67 Sales Y/Y TTM20.48% Profit Margin17.62% Recom2.00 Target Price19.00
Option/ShortYes / Yes LT Debt/Eq0.39 EPS Q/Q-98.04% Payout0.00% Rel Volume0.72 Prev Close18.55
Sales Surprise16.37% EPS Surprise-92.45% Sales Q/Q31.46% EarningsNov 06 AMC Avg Volume610.40K Price18.58
SMA20-2.15% SMA50-4.66% SMA2006.51% Trades Volume438,337 Change0.16%
Date Action Analyst Rating Change Price Target Change
Jun-18-24Initiated Cantor Fitzgerald Overweight
Jul-20-22Initiated Goldman Neutral $16
Nov-20-17Initiated Deutsche Bank Hold $13
Nov-26-24 07:00AM
Nov-21-24 11:14PM
Nov-12-24 04:05PM
Nov-06-24 05:23PM
04:05PM
07:00AM Loading…
Sep-04-24 07:00AM
Jul-31-24 10:54PM
05:51PM
04:05PM
Jul-09-24 01:30PM
Jun-27-24 08:00AM
Jun-18-24 09:51AM
Jun-03-24 07:00AM
May-31-24 07:30AM
May-20-24 04:06AM
02:04PM Loading…
May-10-24 02:04PM
May-08-24 10:57PM
05:09PM
04:05PM
07:00AM
Apr-24-24 07:00AM
Mar-04-24 04:01PM
Feb-29-24 04:56PM
04:37PM
04:05PM
Feb-14-24 02:44AM
Jan-10-24 06:16PM
Nov-18-23 07:03AM
Nov-03-23 06:00AM
Nov-01-23 05:32PM
04:15PM Loading…
04:15PM
04:05PM
Sep-19-23 08:30AM
Sep-18-23 08:00AM
Aug-25-23 04:52PM
Aug-02-23 05:18PM
04:05PM
Jul-23-23 09:22AM
Jul-11-23 08:53PM
08:00AM
Jul-06-23 11:33AM
Jun-26-23 01:27AM
Jun-21-23 08:00PM
Jun-07-23 08:30AM
Jun-06-23 04:05PM
May-24-23 01:49PM
May-23-23 06:42PM
May-11-23 06:45PM
07:42AM
May-09-23 07:45PM
04:32PM
Apr-28-23 05:30PM
Apr-26-23 08:00PM
Apr-18-23 11:22AM
Apr-17-23 04:31PM
09:40AM
09:00AM
Apr-10-23 08:38AM
Apr-05-23 10:05AM
09:53AM
Apr-03-23 12:09PM
Mar-13-23 06:24PM
Feb-28-23 04:10PM
Feb-14-23 04:33PM
Feb-13-23 05:09AM
Jan-23-23 11:07AM
Jan-10-23 04:05PM
Jan-03-23 06:15PM
Dec-28-22 06:15PM
11:07AM
Dec-22-22 06:00PM
Dec-16-22 06:00PM
Nov-30-22 04:30PM
Nov-28-22 09:40AM
Nov-18-22 08:48AM
Nov-17-22 07:11AM
Nov-11-22 09:40AM
05:29AM
Nov-09-22 06:35PM
04:05PM
Oct-31-22 09:40AM
Oct-20-22 10:02AM
Oct-19-22 10:01AM
08:00AM
Oct-14-22 12:20PM
Oct-12-22 08:30AM
Sep-19-22 02:28PM
Sep-08-22 07:00AM
Sep-05-22 11:43AM
Aug-22-22 08:55AM
Jul-27-22 05:55PM
04:05PM
Jul-21-22 11:08AM
Jul-20-22 10:01AM
Jul-14-22 06:04PM
Jul-13-22 05:29PM
04:32PM
04:25PM
Jul-12-22 01:35PM
Jul-11-22 05:07PM
Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.